Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer. [electronic resource]
Producer: 19990209Description: 1107-14 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Aspartate Carbamoyltransferase -- antagonists & inhibitors
- Aspartic Acid -- administration & dosage
- Dipyridamole -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leukocytes -- enzymology
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Phosphonoacetic Acid -- administration & dosage
- Uridine Triphosphate -- metabolism
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.